Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for J2357. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
31
Median % of Medicare
--
Rate range
$18.11 - $54.38
J2357 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Alabama | $44.60 | -- | -- | 2026 |
| Arkansas | $35.82 | -- | -- | 2026 |
| Arizona | $35.87 | -- | -- | 2026 |
| California | $46.28 | -- | -- | 2026 |
| Connecticut | $45.50 | -- | -- | 2026 |
| District of Columbia | $45.50 | -- | Required | 2026 |
| Iowa | $44.11 | -- | -- | 2024 |
| Idaho | $39.31 | -- | Required | 2026 |
| Illinois | $40.69 | -- | -- | 2026 |
| Indiana | $54.38 | -- | Required | 2026 |
| Kansas | $46.59 | -- | -- | 2026 |
| Kentucky | $45.50 | -- | -- | 2026 |
| Maine | $46.59 | -- | -- | 2026 |
| Michigan | $46.59 | -- | -- | 2026 |
| Minnesota | $23.83 | -- | Required | 2025 |
| Mississippi | $46.59 | -- | -- | 2026 |
| Montana | $45.50 | -- | Required | 2026 |
| Nebraska | $46.58 | -- | -- | 2026 |
| New Hampshire | $51.79 | -- | Not required | 2026 |
| New Jersey | $18.11 | -- | Not required | 2026 |
| New Mexico | $37.75 | -- | -- | 2025 |
| Oklahoma | $46.59 | -- | -- | 2026 |
| Rhode Island | $24.30 | -- | -- | 2026 |
| South Carolina | $46.59 | -- | -- | 2026 |
| Texas | $40.56* | -- | -- | 2026 |
| Utah | $46.59* | -- | Required | 2026 |
| Virginia | $46.58* | -- | -- | 2026 |
| Vermont | $42.37 | -- | Required | 2026 |
| Washington | $46.59 | -- | -- | 2026 |
| Wisconsin | $46.59 | -- | -- | 2026 |
| Wyoming | $46.59 | -- | -- | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related drugs codes
- J0013 - Esketamine, nasal spray, 1 mg
- J0120 - Injection, tetracycline, up to 250 mg
- J0121 - Injection, omadacycline, 1 mg
- J0122 - Injection, eravacycline, 1 mg
- J0129 - Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0130 - Injection abciximab, 10 mg
- J0131 - Injection, acetaminophen, not otherwise specified,10 mg
- J0132 - Injection, acetylcysteine, 100 mg
All 157 codes from J2002 to J2998 or every drugs code by number.
Frequently asked questions
How much does Medicaid pay for J2357?
31 state Medicaid programs publish a fee-for-service rate for J2357 (injection, omalizumab, 5 mg), ranging from $18.11 in New Jersey to $54.38 in Indiana. The full table on this page lists every publishing state's current rate.
Which state pays the most for J2357?
Indiana publishes the highest Medicaid rate for J2357 at $54.38. New Jersey publishes the lowest at $18.11.
Does J2357 require prior authorization under Medicaid?
7 of the 31 publishing states flag J2357 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".